Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  apolizumab
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01454, OSU 0410, CLLRC-OSU-0410, CDR0000378072, NCI-6257, R21CA091564, 6257, NCT00089154
Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000067318, UIHC-UICC-LW-02, NCI-T99-0019, T99-0019, NCT00004101
Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01405, OSU 0101, NCI-1254, OSU-00H0230, CDR0000068695, U01CA076576, 1254, NCT00017472
Phase I Study of Apolizumab and Rituximab in Patients With Relapsed CD20 and 1D10-Positive B-Cell Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-01-C-0235, NCI-2410, 2410, NCT00029367
Phase I Study of Monoclonal Antibody Hu1D10 and Filgrastim (G-CSF) in Patients With B-Cell Lymphoproliferative Disorders
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-MC0016, NCI-2470, 2470
Start Over